SECsense Logo

Cero Therapeutics Holdings, Inc. 8-K Report: Key Stock & Warrant Insights

$CERO
Form 8-K
Filed on: 2024-12-31
Source
Cero Therapeutics Holdings, Inc. 8-K Report: Key Stock & Warrant Insights

Based on the provided financial report section, here are the key extracted insights:

  1. Entity Information:
  • Company Name: Cero Therapeutics Holdings, Inc.
  • CIK Identifier: 0001870404
  • Address: 201 Haskins Way, Suite 230, South San Francisco, CA 94080
  • Contact Number: 650-407-2376
  1. Filing Type:
  • Form Filed: 8-K (Current Report)
  1. Reporting Date:
  • As of Date: December 23, 2024
  1. Stock Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Stock Exchange: NASDAQ (Ticker: CERO)
  • Warrants:
    • Each warrant is exercisable for one share of common stock.
    • Warrant Ticker: CEROW
    • Listed on NASDAQ.
  1. Units of Measurement:
  • Financial figures are reported in USD (U.S. Dollars) and shares.
  1. Contextual Information:
  • The filing includes detailed data points regarding the company's common stock and warrants, indicating active securities in the market.

Summary:

Cero Therapeutics Holdings, Inc. has filed an 8-K as of December 23, 2024, reporting key details about its common stock and warrants. The common stock has a par value of $0.0001 per share, and both the common stock and warrants are publicly traded on NASDAQ under the ticker symbols CERO and CEROW, respectively. The report provides essential insights into the company's equity structure and securities.